Filing Details

Accession Number:
0001104659-22-080206
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-15 16:05:58
Reporting Period:
2022-06-23
Accepted Time:
2022-07-15 16:05:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1828185 Vaccitech Plc VACC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1851630 Graham Griffiths C/O Vaccitech Plc, Unit 6-10, Zeus
Building Rutherford Avenue, Harwell
Didcot X0 OX11 0DF
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2022-06-23 1,931 $0.00 117,830 No 4 M Direct
Ordinary Shares Acquisiton 2022-06-23 2,317 $0.00 120,147 No 4 M Direct
Ordinary Shares Acquisiton 2022-06-23 3,090 $0.00 123,237 No 4 M Direct
Ordinary Shares Disposition 2022-06-23 8 $5.28 123,229 No 4 S Direct
Ordinary Shares Acquisiton 2022-06-24 100 $5.87 123,329 No 5 L Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 5 L Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Share Option (Right to Buy) Disposition 2022-06-23 1,931 $0.00 1,931 $0.00
Ordinary Shares Share Option (Right to Buy) Disposition 2022-06-23 2,317 $0.00 2,317 $0.00
Ordinary Shares Share Option (Right to Buy) Disposition 2022-06-23 3,090 $0.00 3,090 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2028-02-16 No 4 M Direct
2,317 2029-08-14 No 4 M Direct
6,180 2030-01-08 No 4 M Direct
Footnotes
  1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  2. These shares were sold to cover the exercise price of options exercised by the Reporting Person.
  3. This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
  4. This option shall vest and become exercisable in four equal annual installments, with the first installment vested on February 1, 2020. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
  5. This option shall vest and become exercisable in four equal annual installments, with the first installment vested on January 1, 2021. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3662 to GBP 1.00 on December 31, 2020.